Latest News & Features
Big Pharma
A district court has upped Vectura’s award of $89.7 million in damages by $10m, after a jury trial earlier this year found that GlaxoSmithKline has willfully infringed one of its patents. 16 September 2019
Big Pharma
The Trump administration has pledged to crack down on the sale of unauthorised vape products, amid growing public health concerns over the safety of e-cigarettes. 12 September 2019
Genetics
The University of Columbia has hit Illumina with a patent infringement suit relating to next-generation DNA sequencing, just days after the pharmaceutical company had one of the university’s patents invalidated at the US Patent and Trial Appeal Board. 12 September 2019
Europe
The world's ”largest genetics project” to tackle deadly diseases was launched yesterday, September 11, supported by funding from the UK government, charities and four pharmaceutical companies. 12 September 2019
article
European Federation of Pharmaceutical Industries and Associations has welcomed a mission letter from the EU president-elect, which promises to invest in new health sector technologies, promote healthy lifestyles and forge better cooperation within the EU. 11 September 2019
Americas
Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation. 10 September 2019
Big Pharma
Held during Boston’s week-long Biotech festival, BioPharm America promises its 4,500 delegates excellent knowledge, networking, and deal opportunities, says Guadalupe Rodriguez of EBD Group. 10 September 2019
Americas
IP services company Clarivate Analytics has acquired patent sequence information provider SequenceBase to expand its search and analysis capabilities for the life sciences IP market. 9 September 2019
Americas
Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime. 9 September 2019
Big Pharma
Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments. 9 September 2019